← ANAPTYSBIO, INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | ($4.3m) |
($30.1m)
-606.03%
|
($61.7m)
-105.04%
|
($97.3m)
-57.87%
|
($19.9m)
+79.52%
|
($57.8m)
-189.98%
|
($128.7m)
-122.72%
|
($163.6m)
-27.11%
|
($145.2m)
+11.24%
|
($13.2m)
+90.89%
|
— | |
| Depreciation, Depletion and Amortization | $233k | $183k | $315k | $514k | $559k | $619k | $675k | $652k | $606k | $559k | $2.4m | |
| Share-based Payment Arrangement, Noncash Expense | $1.2m | $4.4m | — | — | — | — | — | $33.2m | $34.0m | $36.1m | $41.1m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | — | — | $7.5m | $1.5m | — | |
| Share-based Payment Arrangement, Expense | — | — | — | — | — | — | — | — | $34.0m | $36.1m | $41.1m | |
| Nonoperating Income (Expense) | ($1.2m) | ($1.3m) | $4.9m | $9.9m | $3.9m | ($982k) | ($13.5m) | $788k | ($30.3m) | ($61.0m) | — | |
| Other Nonoperating Income (Expense) | ($147k) | $229k | ($159k) | $1k | ($11k) | $37k | $12k | ($2k) | $14k | $5.4m | — | |
| Net Cash Provided by (Used in) Operating Activities | ($9.0m) |
($19.4m)
-115.26%
|
($48.5m)
-149.54%
|
($69.5m)
-43.32%
|
($14.2m)
+79.64%
|
($45.9m)
-224.36%
|
($73.6m)
-60.26%
|
($120.8m)
-64.15%
|
($135.3m)
-12.03%
|
$19.7m
+114.55%
|
$4.5m
-77.27%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $50k | $290k | $1.1m | $805k | $569k | $1.4m | $358k | $807k | $358k | $87k | ($69k) | |
| Gain (Loss) on Disposition of Property Plant Equipment | ($1k) | $0 | $0 | — | $100k | — | — | $0 | — | — | — | |
| Unrealized Gain (Loss) on Investments | — | — | $1.2m | — | — | ($493k) | $2.5m | $10.5m | $10.3m | $4.7m | — | |
| Net Cash Provided by (Used in) Investing Activities | ($50k) | ($243.1m) | ($142.5m) | $131.4m | $94.5m | $38.8m | ($394.8m) | $144.8m | $95.4m | $228.0m | $248.2m | |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common Stock | $1k | $0 | $0 | — | — | $0 | $0 | $50.0m | $456k | $68.6m | — | |
| Proceeds from Issuance of Common Stock | $0 | $292.5m | $227.5m | $0 | $0 | $2.6m | $11.8m | $2.5m | $6.5m | $14.3m | $28.0m | |
| Net Cash Provided by (Used in) Financing Activities | $8.6m |
$292.5m
+3289.58%
|
$223.4m
-23.62%
|
($4.5m)
-102.01%
|
($879k)
+80.44%
|
$252.3m
+28802.84%
|
$44.0m
-82.55%
|
($59.3m)
-234.71%
|
$127.1m
+314.27%
|
($132.6m)
-204.38%
|
($102.8m)
+22.47%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $32.4m | $57.4m | $79.4m | $245.2m | ($424.4m) | ($35.3m) | $87.1m | $115.1m | $248.5m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $51.3m | $81.2m | $113.7m | $171.1m | $250.5m | $495.7m | $71.3m | $36.0m | $123.1m | $238.2m | $248.5m | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $31k | $979k | $2.9m | $3.0m | $496k | $2.1m | $11.3m | $1.8m | $5.3m | $12.9m | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | $1.0m | $424k | $4k | $0 | $0 | — | $42.1m | $80.0m | — | |
| Additional Financial Items | ||||||||||||
| Foreign Currency Transaction Gain (Loss), before Tax | ($100k) | $200k | — | — | — | — | — | — | — | — | — | |
| General and Administrative Expense | $4.3m | $9.3m | $15.5m | $16.1m | $18.9m | $21.5m | $36.6m | $41.9m | $42.4m | $50.7m | — | |
| Income Tax Expense (Benefit) | $0 | $0 | ($192k) | ($152k) | $0 | $0 | $24k | ($4k) | $3k | $164k | — | |
| Investment Income, Interest | $127k | $1.6m | — | — | — | — | — | — | — | — | — | |
| Operating Expenses | $19.7m | $38.8m | $71.7m | $115.4m | $98.9m | $120.0m | $125.4m | $181.6m | $206.2m | $186.7m | — | |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | $5.0m | — | — | — | — | — | — | — | — |